Adenocarcinoma of the Gastroesophageal Junction
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Gastroesophageal Junction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Resilience and Exercise in Advanced Cancer Treatment [NA]
The clinical trial evaluating resilience and exercise in advanced cancer has completed, involving pancreatic adenocarcinoma, gastric adenoca…
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery [Phase 2]
Phase 2 pilot trial of CRLX101 for advanced/metastatic stomach, gastroesophageal junction, or esophageal cancers that are unresectable; tria…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating pralatrexate and oxaliplatin in unresectable or metastatic esophageal, stomach, or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: A Survivorship Care Plan for Gynaecological Cancer Patients
This completed clinical trial update reports on a survivorship care plan study for gynecologic cancer patients sponsored by Royal Marsden NH…
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach [Phase 2]
A completed Phase II exploratory trial evaluating perioperative treatment for adenocarcinoma of the gastroesophageal junction or stomach.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating everolimus in combination with chemotherapy for metastatic stomach or esophageal cancer; res…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
A Phase 2 trial evaluating a chemoradiation regimen of docetaxel, oxaliplatin, capecitabine, and fluorouracil with radiation for locally adv…
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
This entry notes the completion of a clinical trial investigating physical and psychosocial rehabilitation needs in patients after diagnosis…
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial of Epirubicin hydrochloride, Cisplatin, and Fluorouracil or Capecitabine with or without Lapatinib for first-line treatment of…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction [Phase 2]
Phase 2 clinical trial evaluating a regimen of fluorouracil, cisplatin, leucovorin calcium, and cetuximab for adenocarcinoma of the stomach …
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial evaluated chemotherapy with or without vismodegib in patients with advanced stomach or gastroesophageal junction ad…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy [Phase 2]
This Phase 2 trial investigated the combination of pralatrexate and docetaxel in patients with Stage IV esophageal or gastroesophageal cance…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer [Phase 1, Phase 2]
Phase I/II study of oblimersen with cisplatin and fluorouracil in gastric and esophageal cancers; the trial was terminated with results post…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach [Phase 2]
Phase 2 trial evaluating bortezomib with or without irinotecan in gastroesophageal junction and stomach cancers; study completed with result…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma [Phase 2]
Phase II trial evaluating a triplet regimen of oxaliplatin, irinotecan, and capecitabine in advanced gastric and gastroesophageal junction c…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating the combination of sorafenib with docetaxel and cisplatin in patients with metastatic or advanced gastric cancer an…
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction [Phase 2]
This Phase 2 trial tested a multimodal regimen including panitumumab with docetaxel, cisplatin, radiation therapy, and surgery for newly dia…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial results for the Akt inhibitor MK-2206 in advanced gastric and gastroesophageal junction cancers have been posted.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial update of saracatinib for locally advanced or metastatic stomach/ gastroesophageal junction cancer; results posted af…
-
CLINICAL_TRIALS trial_result · 2014-01-21Clinical Trial Update: Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery [Phase 2]
A Phase 2 clinical trial evaluated irinotecan hydrochloride with or without alvocidib in advanced stomach and gastroesophageal junction canc…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. [Phase 2]
A Phase 2 pharmacogenomic study evaluating docetaxel and cisplatin, followed by docetaxel, cisplatin, and irradiation, was terminated.
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
A clinical trial update describing collection of blood and tissue samples from patients with gastric cancer, esophageal cancer, or gastroeso…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer [Phase 2]
A Phase II trial evaluating erlotinib hydrochloride in patients with advanced esophageal cancer and gastroesophageal junction cancer has com…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
This Phase 2 trial evaluated a triplet regimen of irinotecan, cisplatin, and bevacizumab in patients with unresectable or metastatic gastric…
-
CLINICAL_TRIALS research · 2013-05-13Clinical Trial Update: Validation of a Nutrition Screening Tool
Clinical trial update reporting the completion of a study validating a nutrition screening tool across multiple cancer types.